ROLE OF CD44 IN THE INVASIVENESS OF GLIOBLASTOMA-MULTIFORME AND THE NONINVASIVENESS OF MENINGIOMA - AN IMMUNOHISTOCHEMISTRY STUDY

被引:51
作者
ARIZA, A
LOPEZ, D
MATE, JL
ISAMAT, M
MUSULEN, E
PUJOL, M
LEY, A
NAVASPALACIOS, JJ
机构
[1] HOSP UNIV GERMANS TRIAS & PUJOL,DEPT NEUROSURG,E-08916 BADALONA,SPAIN
[2] UNIV AUTONOMA BARCELONA,HOSP SANTA CREU & SANT PAU,DEPT PATHOL,BARCELONA,SPAIN
[3] HOSP ESPERIT SANT,DEPT PATHOL,BARCELONA,SPAIN
[4] FDN ECHEVARNE,BARCELONA,SPAIN
关键词
CD44; MENINGIOMA; GLIOBLASTOMA MULTIFORME; INVASION; METASTASIS; IMMUNOHISTOCHEMISTRY;
D O I
10.1016/0046-8177(95)90278-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD44 is a polymorphic family of cell adhesion molecules that seems to be instrumental in the mechanism of tumor invasion and metastasis. Tumor cell expression of CD44, or lack thereof, may be one of the factors conditioning the highly disparate ability to penetrate the brain extracellular matrix (ECM) exhibited by glioblastoma multiforme (GM) and conventional meningioma. To assess the presence of CD44 in these two tumor types we have immunohistochemically investigated the expression of CD44 standard form (CD44s) and the variant isoforms containing the domain encoded by variant exon 3 (CD44v3) and variant exon 6 (CD44v6) in paraffin-embedded tissue from 10 conventional meningiomas and 10 GMs. A CD44s-/CD44v-phenotype was discerned in the meningioma cases, whereas GMs featured a CD44s+/CD44v- expression profile. Consequently, the growth patterns of meningioma and GM seem to be, at least in part, a reflection of their CD44 expression status. Paucity of CD44 in meningioma cells would render them unable to infiltrate the brain ECM, whereas CD44-rich glioma cells would successfully migrate through it. Conversely, lack of CD44v expression would contribute to explain the lack of metastatic potential characterizing both conventional meningioma and GM. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:1144 / 1147
页数:4
相关论文
共 24 条
[11]   DIFFERENTIAL EXPRESSION OF THE CD44 MOLECULE IN HUMAN BRAIN-TUMORS [J].
KUPPNER, MC ;
VAN MEIR, E ;
GAUTHIER, T ;
HAMOU, MF ;
DETRIBOLET, N .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (04) :572-577
[12]   BINDING OF HYALURONIC-ACID TO LYMPHOID-CELL LINES IS INHIBITED BY MONOCLONAL-ANTIBODIES AGAINST PGP-1 [J].
LESLEY, J ;
SCHULTE, R ;
HYMAN, R .
EXPERIMENTAL CELL RESEARCH, 1990, 187 (02) :224-233
[13]  
LI H, 1993, CANCER RES, V53, P5345
[14]   SIGNIFICANCE OF CD44 GENE-PRODUCTS FOR CANCER-DIAGNOSIS AND DISEASE EVALUATION [J].
MATSUMURA, Y ;
TARIN, D .
LANCET, 1992, 340 (8827) :1053-1058
[15]   HYALURONATE CAN FUNCTION AS A CELL-ADHESION MOLECULE AND CD44 PARTICIPATES IN HYALURONATE RECOGNITION [J].
MIYAKE, K ;
UNDERHILL, CB ;
LESLEY, J ;
KINCADE, PW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (01) :69-75
[16]   STRUCTURAL HETEROGENEITY OF HUMAN PGP-1 AND ITS RELATIONSHIP WITH P85 [J].
OMARY, MB ;
TROWBRIDGE, IS ;
LETARTE, M ;
KAGNOFF, MF ;
ISACKE, CM .
IMMUNOGENETICS, 1988, 27 (06) :460-464
[17]  
PENNO MB, 1994, CANCER RES, V54, P1381
[18]   MONOCLONAL-ANTIBODIES TO HUMAN-LYMPHOCYTE HOMING RECEPTORS DEFINE A NOVEL CLASS OF ADHESION MOLECULES ON DIVERSE CELL-TYPES [J].
PICKER, LJ ;
NAKACHE, M ;
BUTCHER, EC .
JOURNAL OF CELL BIOLOGY, 1989, 109 (02) :927-937
[19]   TUMOR-CELL MIGRATION IN THE CENTRAL-NERVOUS-SYSTEM [J].
PILKINGTON, GJ .
BRAIN PATHOLOGY, 1994, 4 (02) :157-166
[20]   THE EXTRACELLULAR-MATRIX OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEMS - STRUCTURE AND FUNCTION [J].
RUTKA, JT ;
APODACA, G ;
STERN, R ;
ROSENBLUM, M .
JOURNAL OF NEUROSURGERY, 1988, 69 (02) :155-170